Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
[table A posted as supplied by authors]
Online supplement 1: Quality Assessment of diagnostic accuracy study using the QUADAS checklist18
Table A
|
Roovers, E.A., et al., Effectiveness of ultrasound screening for developmental dysplasia of the hip, in Doctoral Thesis 'Post-neonatal ultrasound screening for developmental dysplasia of the hip. A study of cost-effectiveness in the Netherlands'. 2004: University of Twente, Enschede, Netherlands. p. 41-53. |
|||
|
Item |
Description |
Yes/No |
Comments/Further information |
|
1. |
Was the spectrum of patients representative of the patients who will receive the test in practice? |
Yes |
The population was an unselected population as is appropriate for screening. |
|
2. |
Were selection criteria clearly described? |
Yes |
Inclusion criteria were very general, with no detailed criteria for exclusion. |
|
3. |
Is the reference standard likely to correctly classify the target condition? |
No |
Reference test is end of follow-up but as this encompasses decision to treat at any age, it is very possible that some treated infants would have resolved spontaneously and therefore such cases represent over-treatment. Thus the sensitivity of the test will be over estimated. |
|
4. |
Is the time period between reference standard and index test short enough to be reasonably sure that the target condition did not change between the two tests? |
NA |
There is a real possibility that the hip dysplasia will spontaneously resolve between the index text and the reference test if the reference test is conducted at 8 months. This is an important aspect of the reference test and is not a flaw. Unfortunately, because some infants were treated early rather than receiving the reference test at 8 months some information was lost. |
|
5. |
Did the whole sample or a random selection of the sample, receive verification using a reference standard of diagnosis? |
Yes |
It should be noted that as the reference standard was treatment or reference test at 8 months not all children were exposed to the same reference standard. |
|
6. |
Did patients receive the same reference standard regardless of the index test result? |
No |
As above. |
|
7. |
Was the reference standard independent of the index test (i.e. the index test did not form part of the reference standard)? |
No |
|
|
8. |
Was the execution of the index test described in sufficient detail to permit replication of the test? |
Yes |
|
|
9. |
Was the execution of the reference standard described in sufficient detail to permit its replication? |
Yes |
Clinical judgement and various assessments involved, so not exactly the same for each infant. |
|
10. |
Were the index test results interpreted without knowledge of the results of the reference standard? |
Yes |
|
|
11. |
Were the reference standard results interpreted without knowledge of the results of the index test? |
No |
|
|
12. |
Were the same clinical data available when test results were interpreted as would be available when the test is used in practice? |
Yes |
|
|
13. |
Were uninterpretable/ intermediate test results reported? |
Partially Yes |
All infants followed up until a definite decision made, however, there may have been some uninterpretable results. |
|
14. |
Were withdrawals from the study explained? |
Yes |
|
[tableB posted as supplied by authors]
Online Supplement 2. Quality of the included studies
Table B
|
Study |
Study design |
Sufficient description of groups and distribution of prognostic factors? |
Is there an adequate description of the screening process? |
Were the groups comparable on all confounding factors? |
If the groups were not comparable was adequate adjustment for the effects of the confounding factors made? |
Was follow-up long enough for the reported outcomes to occur? |
Is it reported what proportion of unselected newborn population was screened? |
Is it reported what proportion of the screened population was followed-up? |
|
Clegg 199916 |
Retrospective comparator study |
No |
Yes |
No |
No |
Yes |
No |
No |
|
Eggl 199323 |
Retrospective comparator study |
No |
No |
No |
No |
Yes |
No |
No |
|
Grill 199717 |
Retrospective comparator study |
No |
No |
No |
No |
Yes |
No |
No |
|
Holen 200222 |
Randomised controlled trial |
Yes |
Yes |
Yes |
Not applicable |
Yes |
Yes (98%) |
Yes (100%) |
|
Krolo 200326 |
Retrospective comparator study with historical control group |
No |
Yes |
No |
No |
No |
No |
No |
|
Maj 198924 |
Retrospective comparator study |
No |
No |
No |
No |
Yes |
?? |
Yes (66.2%) |
|
Malkawi 199725 |
Retrospective comparator study |
No |
Yes |
No |
No |
Yes |
Yes (100%) |
No |
|
Roovers 200424 |
Prospective cohort study with historical control group |
No |
Yes |
No |
Yes |
Yes |
Yes (82.6%) |
Yes (94.5%) |
|
Rosendahl 199421 |
Randomised controlled trial |
Yes |
Yes |
No |
No |
Yes |
Yes (97.5%) |
Yes (100%) |
|
Tegnander 199428 |
Retrospective comparator study |
No |
Yes |
No |
No |
No |
No (implies 100%) |
No |